Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology’s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
May 15, 2026, 10:28Arjun Law: Transplant Should Always Be a Consideration for Severe AA Irrespective of Donor
-
May 15, 2026, 09:45Finding the Right Balance in Hemophilia Treatment – Global Hemophilia Report
-
May 15, 2026, 09:28Abel Hailu: A New Chapter for Pediatric Oncology and Hematology Care in Ethiopia
-
May 15, 2026, 09:26Abdul Mannan: Does Pregnancy Cause Aplastic Anaemia?
-
May 15, 2026, 09:20Join the Global Conversation on Health Equity in Bleeding Disorders – WFH
-
May 15, 2026, 09:10Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar N62
-
May 15, 2026, 08:59New Perspectives on Cholesterol Screening and Heart Disease Risk – Mass General Brigham
-
May 15, 2026, 07:40Vallabh Janardhan: Thrombectomy Has Transformed What Is Possible for Patients with Life-Threatening Vascular Emergencies
-
May 15, 2026, 07:27Maria Kuzmina: How Chronic Inflammation Affects Extramedullary Hematopoiesis